share_log

前沿生物:前沿生物关于艾可宁?新增维持治疗适应症获得Ⅱ期临床试验批准通知书的自愿性披露公告

Frontier Biology: Frontier Biology About Aikonin? Voluntary Disclosure Notice for Additional Maintenance Treatment Indications Obtaining Approval Notice for Phase II Clinical Trials

SZSI ·  Nov 6, 2024 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more